<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    111, Inc.

    verified_userVerify Profile
    Companies » Consumer Services » Food & Drug Retailers » Drug Retailers

    About 111, Inc.

    111,Inc., co-founded by Gang Yu and Junling Liu in 2010, is a leading digital and mobile healthcare platform in China. By applying advanced Internet and information technology, 111,Inc. is devoted to online medical services and online pharmacy through optimized supply chain and cloud services, to increase the efficiency and transparency of drug retail and distribution. 111,Inc. aims to deliver the best and comprehensive healthcare solutions to Chinese people. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $2,300,000,000
    • SIC CODE
      5912
    • NIN CODE
      ####
    • LEADERSHIP
      Dr. Gang Yu and Junling Liu
    • FOUNDED
      2010
    • EMPLOYEES
      1001-5000
    • SECTOR
      Food & Drug Retailers
    • SUBSECTOR
      Drug Retailers

    Company Tags

    No articles found.

    Simulations Plus, Inc.

    Simulations Plus, Inc.

    Simulations Plus, Inc. is the leading developer of Absorption, Distribution, Metab...

    Simulations Plus, Inc. is the leading developer...

    Filing Type:    PU
    OptiNose, Inc.

    OptiNose, Inc.

    Optinose is a specialty pharmaceutical company focused on creating and bringing to...

    Optinose is a specialty pharmaceutical company ...

    Filing Type:    PU
    Proteostasis Therapeutics, Inc.

    Proteostasis Therapeutics, Inc.

    Proteostasis Therapeutics, Inc. is an innovative biopharmaceutical company committ...

    Proteostasis Therapeutics, Inc. is an innovativ...

    Filing Type:    PU
    Fred's, Inc.

    Fred's, Inc.

    Tracing our history back to an original store in Coldwater, Mississippi in 1947, F...

    Tracing our history back to an original store i...

    Filing Type:    PU
    NowRx, Inc.

    NowRx, Inc.

    NowRx provides a trusted, reliable way to have your prescriptions delivered, from ...

    NowRx provides a trusted, reliable way to have ...

    Amount Raised:    $2,233,127.00
    Fundraising Status:    EC
    Filing Type:    RACF
    China Jo-Jo Drugstores, Inc.

    China Jo-Jo Drugstores, Inc.

    Incorporated in 2006 with headquarters in Hangzhou, China, China Jo-Jo Drugstores,...

    Incorporated in 2006 with headquarters in Hangz...

    Filing Type:    PU
    Digital Turbine, Inc.

    Digital Turbine, Inc.

    Digital Turbine works at the convergence of media and mobile communications, conne...

    Digital Turbine works at the convergence of med...

    Filing Type:    PU
    WhereBy.Us Enterprises, Inc

    WhereBy.Us Enterprises, Inc

    We create local digital publications that use multimedia content and community dat...

    We create local digital publications that use m...

    Amount Raised:    $536,003.67
    Fundraising Status:    SD
    Filing Type:    CF
    Dropbox, Inc.

    Dropbox, Inc.

    Dropbox is a leading global collaboration platform that's transforming the way peo...

    Dropbox is a leading global collaboration platf...

    Filing Type:    PU
    DexCom, Inc.

    DexCom, Inc.

    Founded in 1999, Dexcom, Inc. is the leader in transforming diabetes care and mana...

    Founded in 1999, Dexcom, Inc. is the leader in ...

    Filing Type:    PU
    Bellerophon Therapeutics, Inc.

    Bellerophon Therapeutics, Inc.

    At Bellerophon Therapeutics, we aim to transform the lives of people suffering fro...

    At Bellerophon Therapeutics, we aim to transfor...

    Filing Type:    PU
    Hologic, Inc.

    Hologic, Inc.

    As the leader women’s health, we deliver life-changing and life-saving diagnosti...

    As the leader women’s health, we deliver life...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.